Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PTS Diagnostics, officially known as Polymer Technology Systems, is a global provider of point-of-care diagnostic products designed to manage chronic diseases such as diabetes and cardiovascular conditions. The company is best known for its flagship CardioChek family of analyzers, which provide rapid lipid and metabolic profile results, and the A1CNow+ system for monitoring long-term blood glucose levels. By utilizing advanced material science and proprietary polymer technologies, PTS Diagnostics delivers portable, lab-quality testing solutions that enable immediate clinical decision-making. Headquartered in Indianapolis, the company serves healthcare professionals and patients in over 130 countries, focusing on improving access to essential health data and reducing diagnostic wait times.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polymer Technology.